Published in Int J Colorectal Dis on November 01, 2000
The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas. Am J Hum Genet (2001) 2.68
Prevalence of pathological germline mutations of hMLH1 and hMSH2 genes in colorectal cancer. PLoS One (2013) 0.82
Is reduced expression of mismatch repair genes MLH1 and MSH2 in patients with sporadic colorectal cancer related to their prognosis? Clin Exp Metastasis (2002) 0.82
N-Acetyltransferase (NAT) 2 acetylator status and age of tumour onset in patients with sporadic and familial, microsatellite stable (MSS) colorectal cancer. Int J Colorectal Dis (2006) 0.78
A founder MLH1 mutation in Lynch syndrome families from Piedmont, Italy, is associated with an increased risk of pancreatic tumours and diverse immunohistochemical patterns. Fam Cancer (2014) 0.76
Survival after pancreatoduodenectomy. 118 consecutive resections without an operative mortality. Ann Surg (1990) 7.04
A microsatellite map of wheat. Genetics (1998) 5.21
Global analysis of the general stress response of Bacillus subtilis. J Bacteriol (2001) 3.45
Total knee arthroplasty after open reduction and internal fixation of fractures of the tibial plateau: a minimum five-year follow-up study. J Bone Joint Surg Am (2001) 2.34
Transmission of glioblastoma multiforme through liver transplantation. Lancet (1998) 2.33
Identification and classification of differentially expressed genes in renal cell carcinoma by expression profiling on a global human 31,500-element cDNA array. Genome Res (2001) 2.25
Role of NFkappaB in the mortality of sepsis. J Clin Invest (1997) 2.18
Abundance, variability and chromosomal location of microsatellites in wheat. Mol Gen Genet (1995) 1.80
Poorly differentiated colonic adenocarcinoma, medullary type: clinical, phenotypic, and molecular characteristics. Am J Pathol (1997) 1.73
[Smoking behavior in Germany]. Gesundheitswesen (1999) 1.71
Regulation of MCSF receptors on microglia in the normal and injured mouse central nervous system: a quantitative immunofluorescence study using confocal laser microscopy. J Comp Neurol (1998) 1.67
Identification of SOX2 as a novel glioma-associated antigen and potential target for T cell-based immunotherapy. Br J Cancer (2007) 1.67
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Prevention of venous thromboembolism. International Consensus Statement. Guidelines compiled in accordance with the scientific evidence. Int Angiol (2001) 1.59
Searches for Lepton flavor violation in the decays tau{+/-}-->e{+/-}gamma and tau{+/-}-->mu{+/-}gamma. Phys Rev Lett (2010) 1.44
Gastrin is a target of the beta-catenin/TCF-4 growth-signaling pathway in a model of intestinal polyposis. J Clin Invest (2000) 1.44
Oral, direct Factor Xa inhibition with BAY 59-7939 for the prevention of venous thromboembolism after total hip replacement. J Thromb Haemost (2006) 1.44
Microsatellite instability analysis: a multicenter study for reliability and quality control. Cancer Res (1997) 1.43
Venous thromboembolism--prophylactic and therapeutic practice guideline. S Afr Med J (2009) 1.42
High-level expression of Rad51 is an independent prognostic marker of survival in non-small-cell lung cancer patients. Br J Cancer (2005) 1.42
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
[Resection of solitary liver metastases of malignant melanoma]. Chirurg (1995) 1.39
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Maintenance of warfarin therapy at an anticoagulation clinic. S Afr Med J (2007) 1.39
Procedural complications of electroconvulsive therapy: assessment and recommendations. South Med J (1993) 1.39
Treatment of male infertility: the ICSI revolution is secure. N Z Med J (1996) 1.38
The inhibitory potency and selectivity of arginine substrate site nitric-oxide synthase inhibitors is solely determined by their affinity toward the different isoenzymes. Mol Pharmacol (2000) 1.37
Genesis of cerebral aneurysms--an update. Acta Neurochir (Wien) (2001) 1.37
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
DHPLC mutation analysis of the hereditary nonpolyposis colon cancer (HNPCC) genes hMLH1 and hMSH2. J Biochem Biophys Methods (2001) 1.30
[Laparoscopic cholecystectomy in isolated gallbladder metastasis of malignant melanoma]. Chirurg (2000) 1.28
Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27
Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19
Factors influencing survival after resection of pulmonary metastases from colorectal cancer. Br J Surg (2004) 1.15
Search for a supersymmetric partner to the top quark in final states with jets and missing transverse momentum at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.13
ADAM9 expression in pancreatic cancer is associated with tumour type and is a prognostic factor in ductal adenocarcinoma. Br J Cancer (2004) 1.11
Inter- and intra-subject variability in gabapentin absorption and absolute bioavailability. Epilepsy Res (2000) 1.09
Glutamate dehydrogenase from Medicago sativa L., purification and comparative kinetic studies of the organ-specific multiple forms. Z Naturforsch C (1980) 1.08
Search for tb resonances in proton-proton collisions at √s=7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.07
Precise measurement of the e+e- --> pi+pi-(gamma) cross section with the initial state radiation method at BABAR. Phys Rev Lett (2009) 1.07
Thrombophilia and venous thromboembolism. International consensus statement. Guidelines according to scientific evidence. Int Angiol (2005) 1.06
Efficacy and safety of a low-molecular-weight heparin and standard unfractionated heparin for prophylaxis of postoperative venous thromboembolism: European multicenter trial. World J Surg (1997) 1.06
Measurement of |V(cb)| and the form-factor slope in B --> Dl- nu(l) decays in events tagged by a fully reconstructed B meson. Phys Rev Lett (2010) 1.05
Meta- and pooled analyses of the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and colorectal cancer: a HuGE-GSEC review. Am J Epidemiol (2009) 1.05
Search for a light Higgs boson decaying to long-lived weakly interacting particles in proton-proton collisions at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.05
Association of RET protooncogene codon 45 polymorphism with Hirschsprung disease. Am J Hum Genet (1999) 1.04
Sequence analysis of the mismatch repair gene hMSH6 in the germline of patients with familial and sporadic colorectal cancer. Int J Cancer (2000) 1.02
Resection of pancreatic cancer--surgical achievements. Langenbecks Arch Surg (1998) 1.02
Cell interaction and its role in mesoderm cell migration during Xenopus gastrulation. Dev Dyn (1992) 1.02
Linkage genome scan for loci predisposing to panic disorder or agoraphobia. Am J Med Genet (2001) 1.01
Regulation of thrombospondin in the regenerating mouse facial motor nucleus. Glia (1996) 1.01
A general role for c-Fos in cellular protection against DNA-damaging carcinogens and cytostatic drugs. Cancer Res (1997) 1.01
Expression of TRAIL and its receptors in human brain tumors. Biochem Biophys Res Commun (1999) 1.00
First workshop for detection of heparin-induced antibodies: validation of the heparin-induced platelet-activation test (HIPA) in comparison with a PF4/heparin ELISA. Thromb Haemost (1999) 1.00
Search for supersymmetry in events with three leptons and missing transverse momentum in √[s]=7 TeV pp collisions with the ATLAS detector. Phys Rev Lett (2012) 0.99
The p53 codon 72 variation is associated with the age of onset of hereditary non-polyposis colorectal cancer (HNPCC). J Med Genet (2005) 0.99
Cathepsin C gene variants in aggressive periodontitis. J Dent Res (2008) 0.99
[Low T3 syndrome in multiple trauma patients--a phenomenon or important pathogenetic factor?]. Med Klin (Munich) (1999) 0.98
[Anastomotic ulcer following Whipple's operation with stomach preservation]. Zentralbl Chir (1982) 0.98
Asynchronous optical sampling for high-speed characterization of integrated resonant terahertz sensors. Opt Lett (2005) 0.98
Molecular analysis of aerobic phenylacetate degradation in Azoarcus evansii. Mol Genet Genomics (2002) 0.97
Single unit recordings from the geniculate ganglion of the facial nerve of the cat. Exp Brain Res (1971) 0.97
Pancreatic disorders and diabetes mellitus. Exp Clin Endocrinol Diabetes (2008) 0.96
A controlled trial of intrauterine insemination for cervical factor and male factor: a preliminary report. Int J Fertil (1989) 0.96
Morphological basis for the spectrum of clinical deficits in spinocerebellar ataxia 17 (SCA17). Brain (2006) 0.96
Human platelets as a model for the binding and degradation of thrombopoietin. Blood (1997) 0.95
A model for the detection of clonality in marked hematopoietic stem cells. Ann N Y Acad Sci (2001) 0.95
Malignant neurofibroma of the urinary bladder. Eur Urol (1995) 0.95
Newcastle disease virus-infected intact autologous tumor cell vaccine for adjuvant active specific immunotherapy of resected colorectal carcinoma. Clin Cancer Res (1996) 0.93
Comparison of [18F]FHPG and [124/125I]FIAU for imaging herpes simplex virus type 1 thymidine kinase gene expression. Eur J Nucl Med (2001) 0.93
An intronic germline transition in the HNPCC gene hMSH2 is associated with sporadic colorectal cancer. Eur J Cancer (1997) 0.92
Directional mesoderm cell migration in the Xenopus gastrula. Dev Biol (1991) 0.92
Evidence for inhibition of MyEF-2 binding to MBP promoter by MEF-1/Pur alpha. J Cell Biochem (1997) 0.92
A comparative trial of a low molecular weight heparin (enoxaparin) versus standard heparin for the prophylaxis of postoperative deep vein thrombosis in general surgery. Am J Surg (1995) 0.91
Mesoderm migration in the Xenopus gastrula. Int J Dev Biol (1996) 0.91
Gabapentin bioavailability: effect of dose and frequency of administration in adult patients with epilepsy. Epilepsy Res (1998) 0.91
Anticoagulation: the present and future. Clin Appl Thromb Hemost (2001) 0.91
Novel mutations in the cathepsin C gene in patients with pre-pubertal aggressive periodontitis and Papillon-Lefèvre syndrome. J Dent Res (2004) 0.90
Frequent loss of heterozygosity at the 19p13.3 locus without LKB1/STK11 mutations in human carcinoma metastases to the brain. J Neurooncol (2000) 0.90
Infrequent genetic alterations of the tumor suppressor gene PTEN/MMAC1 in squamous cell carcinoma of the oral cavity. J Oral Pathol Med (2002) 0.90
Spontaneous regression of hepatocellular carcinoma confirmed by surgical specimen: report of two cases and review of the literature. Langenbecks Arch Surg (1998) 0.90
A randomized, double-blind study of certoparin vs. unfractionated heparin to prevent venous thromboembolic events in acutely ill, non-surgical patients: CERTIFY Study. J Thromb Haemost (2010) 0.90
[Dabigatran therapy--perioperative management and interpretation of coagulation tests]. Hamostaseologie (2012) 0.90
Identification of uncommon chromosomal aberrations in the neuroglioma cell line H4 by spectral karyotyping. J Neurooncol (2001) 0.90